MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

ORGS Orgenesis Inc Forecast, Technical & Fundamental Analysis

a development stage company, which focuses on treatment of diabetes

Industry Biotechnology
ORGS
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For ORGS
(Try 14 days for $1 only)
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ORGS
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For ORGS
(Try 14 days for $1 only)
Ad is loading...
A.I. Advisor
published Earnings

ORGS is expected to report earnings to fall 26.09% to 17 cents per share on November 08

Orgenesis Inc ORGS Stock Earnings Reports
Q3'24
Est.
$0.17
Q2'24
Beat
by $0.09
Q1'24
Missed
by $0.33
Q4'23
Missed
by $1.34
Q3'23
Beat
by $0.33
The last earnings report on August 09 showed earnings per share of 23 cents, beating the estimate of 14 cents. With 16.27K shares outstanding, the current market capitalization sits at 25.29M.
A.I. Advisor
published General Information

General Information

a development stage company, which focuses on treatment of diabetes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
20271 Goldenrod Lane
Phone
+1 480 659-6404
Employees
167
Web
https://www.orgenesis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY577.99-5.33
-0.91%
SPDR® S&P 500® ETF Trust
BTC.X66432.195000-929.210940
-1.38%
Bitcoin cryptocurrency
GME20.54-0.39
-1.86%
GameStop Corp
TSLA213.65-4.32
-1.98%
Tesla
AAPL230.76-5.10
-2.16%
Apple

ORGS and Stocks

Correlation & Price change

A.I.dvisor tells us that ORGS and LOGC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORGS and LOGC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGS
1D Price
Change %
ORGS100%
-5.74%
LOGC - ORGS
29%
Poorly correlated
N/A
FATE - ORGS
27%
Poorly correlated
-5.02%
KMSTF - ORGS
25%
Poorly correlated
N/A
CRBU - ORGS
24%
Poorly correlated
-3.03%
AXON - ORGS
24%
Poorly correlated
-1.54%
More